Catalyst Wire Dossier Catalyst Wire Dossier

Darbepoetin alfa (Aranesp)

darbepoetin alfa · Amgen
Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for Darbepoetin alfa (Aranesp), covering 2009-03-13 to 2024-10-30. Get the full timeline:

Most recent: Clinical Trial Update: Darbepoetin Trial to Improve Red Cell Mass and Neuroprotection in Preterm Infants [Phase 3]

See pricing